Drug-resistant depression, three phase III studies confirm l

Esketamine nasal spray formulation combined with a treatment-resistant oral antidepressant for depression has been shown to reduce the severity of the mood disorder and resulted in numerically greater remissions during …

Read more

Drug-resistant depression, three phase III studies confirm l

Esketamine nasal spray formulation combined with a treatment-resistant oral antidepressant for depression has been shown to reduce the severity of the mood disorder and resulted in numerically greater remissions during …

Read more